Company intelligence / Profile preview

JC Discovery

Marseille, Provence-Alpes-Côte d'Azur, Francejc-discovery.com ↗

Ownership: Private
Development stage: Preclinical

Overview

JC Discovery provides advanced preclinical services using gene-edited animal models and high-content immune profiling to support drug discovery in immunology-related fields. It offers innovative translational approaches with expertise in functional genomics, immune system modeling, and mechanistic studies for pharma/biotech partners. The company leverages academic partnerships to deliver predictive models that improve clinical translatability of new therapies.

Therapeutic areas: OncologyImmunology
Modalities: Cell therapyGene editingCAR-T cell therapyTCR-T cell therapy
Industry: Drug Discovery Services

Partnerships

Center of Immunophenomics (CIPHE)Janvier LabsInstitut CurieCenter of Immunology Marseille-Luminy (CIML)

Beyond the preview

Go deeper on JC Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JC Discovery.

Explore the full profile